Mr. Williamson is the founder of LaSalle Venture Advisors, a US-based consultancy serving venture-backed and public life science companies and their investors on strategic and operational issues, including licensing, partnerships, financing and M&A. He currently serves as a non-executive director of Pharmasset Inc. (VRUS), an anti-viral therapeutics company.
From 2004 to 2006, Mr. Williamson served as President and CEO of Arriva Pharmaceuticals, Inc., a privately-held clinical stage respiratory and dermatological therapeutic company and helped the company raise $27 million in venture capital. Previously, Mr. Williamson was President and Chief Operating Officer of EOS Biotechnology, Inc., a therapeutic antibody and genomics company, where he was responsible for operations, business development and finances, and was instrumental in the company's sale to Protein Design Labs, now known as PDL BioPharma (PDLI). Prior to this, Mr. Williamson was President and Chief Operating Officer of DoubleTwist, Inc. (formerly Pangea Systems), a genomics start-up, where he helped the company expand its business model to include genomics content, informatics services and software. Mr. Williamson began his career at The Boston Consulting Group, Inc., a global business consulting firm, where he was named a Partner, and led the firm's west coast health care practice.
Dr. Mal Eutick, OAM
Dr. Eutick has 25 years experience in the medical and pharmaceutical industry including with companies such as Pfizer and Pharmacia.
In 1993, Dr. Eutick founded the highly successful critical medicine pharmaceutical company, Phebra (formerly Pharmalab). He acquired TUTA Healthcare in 2000 from a Japanese multinational and recently coordinated its acquisition by safety medical and collections solutions company BMDI International (BMI) in February 2008.
Dr. Eutick was awarded the Medal of the Order of Australia for Services
to Biotechnology in 1995, for the development an
|SOURCE Progen Pharmaceuticals Limited|
Copyright©2008 PR Newswire.
All rights reserved